Occudo Quantitative Strategies LP Immunity Bio, Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.35 - $4.78 $538,712 - $1.91 Million	399,046 New	399,046 $726,000
Q1 2022 May 16, 2022	SELL	$5.05 - $7.53 $241,642 - $360,310	-47,850 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.67 - $10.18 $154,065 - $276,610	-27,172 Reduced 36.22%	47,850 $291,000
Q3 2021 Nov 15, 2021	BUY	$9.17 - $14.24 $507,311 - $787,799	55,323 Added 280.84%	75,022 $731,000
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $264,163 - $441,257	19,699 New	19,699 $281,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.03B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.